Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Jeff Duncan sells stocks in Colgate-Palmolive and JD.com from his Raymond James IRA

Published 05/25/2024, 05:08 AM
© Reuters.
CL
-
JD
-

South Carolina's 3rd congressional district representative, Jeff Duncan, has recently made two significant stock transactions. The trades involved stocks of Colgate-Palmolive Company (NYSE:CL) and JD (NASDAQ:JD).com, Inc. - American Depositary Shares (NASDAQ:JD).

The transactions, which took place on August 25, 2023, saw Duncan sell shares in both companies. The dollar value of each trade falls within the range of $1,001 to $15,000.

These transactions occurred within Duncan's Individual Retirement Account (IRA) held at Raymond James. The representative's decision to sell these stocks was prompted by a balance requirement at Raymond James of $10,000. To maintain this balance, Duncan was compelled to sell the stocks.

Following the sale, Duncan rolled the balance into his Thrift Savings Plan (TSP) via the TSP rollover process. He did not have direct access to these funds during the process, ensuring the move remained tax-deferred.

This move is significant as it highlights the shift of Duncan's investments from individual stocks to a more diversified retirement savings plan. It also reflects the necessary adjustments that investors sometimes have to make to comply with the balance requirements of their investment accounts.

InvestingPro Insights

Colgate-Palmolive Company (NYSE:CL), one of the stocks recently sold by Representative Jeff Duncan, has been a topic of interest among analysts. According to InvestingPro Tips, the company has an impressive track record of raising its dividend for 34 consecutive years. This demonstrates a strong commitment to returning value to shareholders over an extended period. Moreover, Colgate-Palmolive operates with a moderate level of debt, which suggests a prudent approach to financial management—a factor that could be reassuring for conservative investors.

On the financial side, the InvestingPro Data metrics reveal a company with a market capitalization of $76.56 billion and a P/E ratio of 29.53, which adjusts to 28.56 for the last twelve months as of Q1 2024. The gross profit margin stands at a robust 59.0%, indicating the company's ability to maintain profitability despite various market conditions. Additionally, Colgate-Palmolive's revenue growth for the last twelve months as of Q1 2024 is reported at 7.71%, showcasing its capacity to expand its business operations.

Investors considering Colgate-Palmolive as part of their portfolio may find these insights particularly valuable, especially in light of recent trading activities by congress members. For those interested in further analysis and additional tips, InvestingPro offers a comprehensive view with a total of 13 InvestingPro Tips for Colgate-Palmolive. To gain deeper insights and access these tips, consider using the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.